Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)
During the Trading Day
| 60.02 |  -0.09 / -0.15% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 60.02 |  0.00 / 0.00% |
Volume: 9.8K |
Latest AEGR News | Press Releases
| Aegerion Stock Falls On Unusually High Volume (AEGR) May 17 / TheStreet.com | 4 Stocks Improving Performance Of The Health Care Sector May 16 / TheStreet.com |
Today’s Trading
| Previous close | 60.11 |
| Today’s open | 60.20 |
| Day’s range | 59.50 - 61.19 |
| Volume | 350,685 |
| Average volume (3 months) | 630,342 |
| Market cap | $1.7B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -30.05% |
| Earnings growth (this year) | +14.53% |
| Earnings growth (next 5 years) | +301.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 25.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMGNImmunogen Inc | +0.18 | +1.06% |
| GEVASynageva Biopharma C... | +0.73 | +1.88% |
| HALOHalozyme Therapeutic... | +0.02 | +0.26% |
| ITMNInterMune Inc | -0.14 | -1.38% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman David I. Scheer |
Chief Executive Officer & Director Marc D. Beer |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
